Table 2.
Prevalence of comorbidities and relationships with the CAT score
| |
|
CAT score |
|
|
|---|---|---|---|---|
| Comorbidity | Prevalence (%) | Comorbidity (+) | Comorbidity (−) | p value |
| GERD(FSSG ≥ 8) |
34 |
16.3 ± 9.1 |
10.5 ± 7.2 |
<.0001 |
| Anxiety (HAD-A ≥ 11) |
7 |
20.0 ± 11.9 |
12.1 ± 7.7 |
<.0001 |
| Depression (HAD-D ≥ 11) |
10 |
19.8 ± 10.2 |
11.8 ± 7.6 |
<.0001 |
| Osteoporosis |
18 |
14.9 ± 9.6 |
11.5 ± 7.6 |
0.013 |
| Hypertension |
36 |
12.4 ± 8.7 |
12.6 ± 8.0 |
NS |
| Diabetes mellitus |
15 |
13.0 ± 8.3 |
12.4 ± 8.3 |
NS |
| Dyslipidemia |
17 |
11.3 ± 8.9 |
12.7 ± 8.2 |
NS |
| Hyperuricemia |
8 |
13.4 ± 9.4 |
12.4 ± 8.2 |
NS |
| Coronary artery disease |
13 |
12.1 ± 8.0 |
12.5 ± 8.4 |
NS |
| Chronic heart failure |
8 |
13.8 ± 7.1 |
12.4 ± 8.4 |
NS |
| Arrhythmia |
11 |
15.2 ± 9.8 |
12.1 ± 8.0 |
0.031 |
| Cerebral infarction |
7 |
12.9 ± 8.5 |
12.5 ± 8.3 |
NS |
| Peptic ulcer |
8 |
14.0 ± 8.9 |
12.3 ± 8.2 |
NS |
| Lung cancer |
6 |
12.9 ± 7.8 |
12.5 ± 8.3 |
NS |
| Other malignancies | 19 | 13.1 ± 8.2 | 12.4 ± 8.3 | NS |
Data are presented as means ± SD.
NS Not significant, CAT COPD assessment test, GERD Gastro-esophageal reflux disease, FSSG Frequency Scale for the Symptoms of GERD, HAD-A The seven items for anxiety of Hospital Anxiety and Depression Scale, HAD-D The seven items for depression of Hospital Anxiety and Depression Scale.